ICH M10 Guideline Draft: Are Standard Report Templates Efficient, Feasible, and Practical?

ICH M10 Guideline Draft: Are Standard Report Templates Efficient, Feasible, and Practical?

The Direct & Prescriptive 2019 ICH M10 Guideline Draft

How the ICH M10 Guideline Draft Will Influence Sponsors & SOPs

ICH M10 Guideline Draft: Methods of the QC in Validation Processes

Panel discussion: ICH M10 draft bioanalytical method validation guideline

Podcast: Enabling Tomorrow’s Breakthroughs Today

Business of Bioanalysis: Differing Priorities and Requirements in Choosing Platforms

Business of Bioanalysis: Focusing on the Bioanalytical Data’s End Use

Supporting Strong Partnerships with Bioanalysis Sponsor Companies

Business of Bioanalysis: Changing Trends & the Impact on New Technologies

Business of Bioanalysis: Reverse Engineering Technology Requirements

Business of Bioanalysis: Forward Looking Vendors as an Ideal Partner

Business of Bioanalysis: Evolving the Use of Bioanalytical Platforms

Business of Bioanalysis: The Spread of Drug Development Throughout the World

Business of Bioanalysis: The Inherent Risk in Depending on a Single Platform

Introducing Technology Improvements During a Bioanalysis Study

Business of Bioanalysis: Investing in Technology Implementation

Business of Bioanalysis: Forming Partnerships to Justify New Technology Investments

Business of Bioanalysis: Understanding ROI in Platform Selection

Business of Bioanalysis: The Challenges of Software Validation

Business of Bioanalysis: Merger and Acquisition Challenges for CROs

Business of Bioanalysis: Creating Additional Value Through M&A

The Importance of Company Culture in CRO Mergers

Business of Bioanalysis: Change in the Pharma Industry Creates Opportunities

Business of Bioanalysis: The Impact of Pharma Mergers on CROs

Business of Bioanalysis: The Importance of Soft Skills for Scientists

Bioanalytical Opportunities for Diverse Backgrounds

Business of Bioanalysis: How we Develop Scientists Through Functional Project Teams

Business of Bioanalysis: Supporting the Diverse Needs of Our Employees

Business of Bioanalysis: Our Commitment to Employee Recognition

Business of Bioanalysis: How We Identify and Train Quality Scientific Talent

Business of Bioanalysis: When to Bring in New Bioanalytical Technology

Business of Bioanalysis: Investing in Innovative Bioanalytical Technology

The BioAgilytix Way: Our Unique Approach to Large Molecule Bioanalysis

Virtual Podium: Biomarkers for Heart Disease in African American Women with Lupus

Virtual Podium: Biomarkers and Alzheimer’s Disease

Virtual Podium: Seeking the Biomarkers of Alzheimer’s Disease – On Our Mind

Virtual Podium: Biomarkers for Lupus Diagnosis and Disease Activity

Virtual Podium: How is Your Assay Performing? Biomarker Validation Best-Practices

Virtual Podium: An Analytical Approach to Platform Comparison

Virtual Podium: What’s Your System for Cell-Based Assay Method Selection

Virtual Podium: Western Blot Protocol